Item Qty Item Total
Your cart is empty.
*Subtotal does not include tax, promos or shipping

2/25/2015 - New York Attorney General Investigation Letter

On February 23, 2015, Nature’s Way received a letter which constituted “a request for documents and information relating to an ongoing investigation by the New York State Office of the Attorney General (“NYAG”) concerning the authenticity and purity of herbal dietary supplements and associated marketing.” The letter from the NYAG makes no allegations against Nature’s Way and provides no indications of any quality or compliance problem with any Nature’s Way product. The letter is simply a “request” for documents and information.

Nature’s Way products are produced in accordance with the federal Food and Drug Administration’s (FDA’s) Dietary Supplement Good Manufacturing Practices (GMPs), 21 CFR 111. Nature’s Way is audited by FDA to confirm compliance and continues to hold Dietary Supplement GMP Certification through NSF International, a GMP Certificate from the Australian Department of Health’s Therapeutic Goods Association (TGA) and is a licensed site for the production of Natural Health Products (NHPs) marketed in Canada. Nature’s Way intends to cooperate with the NYAG request for documents and information, as we are proud of our Quality Assurance processes and the steps that we take to both comply with the law and produce products of the highest quality.


For Immediate Release:

Schwabe CEO Randy J. Rose to Retire

GREEN BAY, WI, November 15, 2011 — Schwabe North America announces Randy J. Rose will retire as President and Chief Executive Officer effective January 1, 2012.

GREEN BAY, WI, November 15, 2011 — Schwabe North America announces Randy J. Rose will retire as President and Chief Executive Officer effective January 1,, 2012. Rose has served in the leadership role since 2002, first as CEO of Enzymatic Therapy, Inc. before its acquision by Dr. Willmar Schwabe GmbH & Co. KG, in 2008, and since the acquistion for the combined businesses of Nature’s Way, Integrative Therapeutics, and Enzymatic Therapy, makers of leading health and wellness natural medicine products.

Rose will be succeeded by Michael. P. Devereux. Devereux has held senior roles within the company since 2001, including Chief Financial Officer and Chief Operating Officer.

“It has been my great honor to work with a terrific team that is dedicated to improving the lives and wellbeing of others,” stated Rose. “We have made great strides over the last decade and I have every confidence that the company will continue to prosper as it continues forward on its mission of ,‘Enhancing life through the power of nature.’”

Headquartered in Green Bay, Wisconsin, Schwabe North America employs 543 people and is the leading branded manufacturer of natural medicines sold in health food stores. The company was recently recognized with a “Manufacturer of Distinction” award from the Green Bay Chamber of Commerce on November 7, and has received numerous awards throughout the years from the natural products industry for product innovation and high standards of quality. The company’s best-selling products include Alive!™ multiple vitamins, and Pearls ™ probiotics, which are sold at fine retailers everywhere.

Schwabe North America operates manufacturing and distribution facilities to US FDA pharmaceutical standards, and has earned regulatory and quality verification approvals by European and Australian regulatory agencies. The company has offices in Green Bay, Wisconsin, Lehi, Utah, Vancouver, British Columbia, and Markem, Ontario.

For more information, visit,,, and